No #$%$, I'm not you. I'm a long who wants justice and the share price to get back where it belongs. I believe in the company and products BUT DO NOT BELIEVE in current management at all.
Maybe the offering will be 26,000,000 shares at a nickel...longs have had it way too good for way too long...
Was the Crede deal your wish? This management team is capable of anything unimaginably bad for shareholders...
With the pps currently and disgustingly at 1.35, the next offering is going to REALLY ruin the pps worse than anyone could have imagined (except Pykett, Tulip, and Larson) before the Crede deal...
They will cover with the next share offering that Navidea offers them as a PRIVATE PLACEMENT:
26,000,000 shares for ten cents each! Gets the shorts off with a huge gain AND knocks the pps 90% lower than it is now! Longs get kicked in the face all the way and shorts make even more money! Don't laugh! It sure seems likely given how management does nothing but disrespect shareholders.
Management seems SO INTENT on harming shareholders that it seems as if MANAGEMENT will help the shorts cover by doing a private placement to the shorts for 26,000,000 shares at ten cents each!
in the absence of a real PDUFA run that the shorts have not had to spend much ammunition to hold the price down. Accordingly, upon approval, they will likely have oodles of shares to make sure the pps does not see even 1.50, though I have to admit, right now even 1.40 seems unlikely with approval.
Larson and Tulip need to be replaced. Next year's salary FOR THEIR REPLACEMENTS should be solely based on regulatory progress with the pipeline and Lymphoseek sales. Shareholder lawsuits should result otherwise. Period. I do not believe shareholders will be so patient for ever.
They are much more concerned about racking up millions of dollars in bonuses for annual sales less than 5% of current marketcap. Indeed, why should they receive 5 million dollars in bonuses WHEN LYMPHOSEEK SALES FOR THE YEAR WILL BE BARELY 5 MILLION DOLLARS?
All salary next year should be sales/profit based and stock performance price based...period.
In early November, the third quarterly report is due and of course, Q3 is over this coming Tuesday 9/30. The company has already said that they expect $5-6 million for 2014 and considering that only $1.3 million was shown between Q1 and Q2, the company damn well better be releasing quarterly income of around $2 million in November.
Potentially great news today and the stock is neutral. Management needs replacing ASAP. To hell with cutting their pay. Cut THEM out!
Great dreams and optimism, but lets see 2.00 first and Brent Larson break a sweat on the job before we publicly dream so big. Larson sold at 1.99 back in March. Damn him!
release great news after the bell. I like the news, really! I do not like the way the company has repeatedly released news in a fashion that does nothing for the share price and shareholders! What are the motives for their bs?
Instead, the stock is trading as if it could be under 1.00 any day now...and stay there forever. I'm sure the good folks at Navidea are hard at work planning the next secondary offering to further destroy the stock price and fatten their own F---- wallets.
He gets a $750K buyout for destroying the stock price and gets to move to a new job where he can do the same damage again and again. May the shareholders of the new company beware in advance of him.
It's going to be a 2016 story.
Regardless of "how good" the science is behind their products, THE SHARE PRICE is ALWAYS the lowest priority AND BOY DOES IT SHOW.
Hard to argue with that...
I would love to be more optimistic in general about this company, but the pps has lingered FOR FAR TOO LONG UNDER 1.50 and with October approaching AND EU Approval approaching this may change, BUT IF EITHER OF THESE CATALYSTS FAILS TO MATERIALIZE look out below. I expect 2 approvals before year end, but this company has proved FULL of negative surprises since CREDE...enough said.
that more partnerships are on the way tells me that within 2 years, we will very likely see a major turnaround and a pps North of 3.00 by September 2016. I'm not celebrating this length of time to reach 3.00+, but I feel better about it than saying by September of 2016 the company will no longer exist...GLTA.
they seem to be having trouble keeping it there. The October PDUFA is far bigger that the two previous Lymphoseek FDA approvals. Accordingly, how high can we get before October? Then again, why even ponder such things...pup says we are all doomed. LOL.